Pila Pharma (Sweden) Performance
| PILA Stock | 1.14 0.07 5.79% |
The company holds a Beta of 0.11, which implies not very significant fluctuations relative to the market. As returns on the market increase, Pila Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pila Pharma is expected to be smaller as well. At this point, Pila Pharma AB has a negative expected return of -0.97%. Please make sure to check Pila Pharma's value at risk, skewness, and the relationship between the maximum drawdown and potential upside , to decide if Pila Pharma AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Pila Pharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Pila |
Pila Pharma Relative Risk vs. Return Landscape
If you would invest 235.00 in Pila Pharma AB on November 26, 2025 and sell it today you would lose (121.00) from holding Pila Pharma AB or give up 51.49% of portfolio value over 90 days. Pila Pharma AB is generating negative expected returns and assumes 6.8759% volatility on return distribution over the 90 days horizon. Simply put, 61% of stocks are less volatile than Pila, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Pila Pharma Target Price Odds to finish over Current Price
The tendency of Pila Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.14 | 90 days | 1.14 | under 95 |
Based on a normal probability distribution, the odds of Pila Pharma to move above the current price in 90 days from now is under 95 (This Pila Pharma AB probability density function shows the probability of Pila Stock to fall within a particular range of prices over 90 days) .
Pila Pharma Price Density |
| Price |
Predictive Modules for Pila Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pila Pharma AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Pila Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pila Pharma is not an exception. The market had few large corrections towards the Pila Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pila Pharma AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pila Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.87 | |
β | Beta against Dow Jones | 0.11 | |
σ | Overall volatility | 0.46 | |
Ir | Information ratio | -0.14 |
Pila Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pila Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pila Pharma AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pila Pharma AB generated a negative expected return over the last 90 days | |
| Pila Pharma AB has high historical volatility and very poor performance | |
| Pila Pharma AB may become a speculative penny stock | |
| Pila Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 719.23 K. Net Loss for the year was (17.21 M) with profit before overhead, payroll, taxes, and interest of 680.94 K. | |
| Pila Pharma generates negative cash flow from operations | |
| About 43.0% of the company outstanding shares are owned by corporate insiders |
Pila Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pila Stock often depends not only on the future outlook of the current and potential Pila Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pila Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 31.5 M | |
| Cash And Short Term Investments | 28.2 M |
Pila Pharma Fundamentals Growth
Pila Stock prices reflect investors' perceptions of the future prospects and financial health of Pila Pharma, and Pila Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pila Stock performance.
| Return On Equity | -1.3 | |||
| Return On Asset | -0.27 | |||
| Operating Margin | (4.58) % | |||
| Current Valuation | 48.17 M | |||
| Shares Outstanding | 18.41 M | |||
| Price To Book | 7.07 X | |||
| Price To Sales | 25.21 X | |||
| Revenue | 719.23 K | |||
| EBITDA | (17.16 M) | |||
| Book Value Per Share | 0.47 X | |||
| Cash Flow From Operations | (9.36 M) | |||
| Earnings Per Share | (1.72) X | |||
| Total Asset | 31.81 M | |||
About Pila Pharma Performance
Assessing Pila Pharma's fundamental ratios provides investors with valuable insights into Pila Pharma's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Pila Pharma is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Pila Pharma AB performance evaluation
Checking the ongoing alerts about Pila Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pila Pharma AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pila Pharma AB generated a negative expected return over the last 90 days | |
| Pila Pharma AB has high historical volatility and very poor performance | |
| Pila Pharma AB may become a speculative penny stock | |
| Pila Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 719.23 K. Net Loss for the year was (17.21 M) with profit before overhead, payroll, taxes, and interest of 680.94 K. | |
| Pila Pharma generates negative cash flow from operations | |
| About 43.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Pila Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pila Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Pila Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pila Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pila Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pila Pharma's stock. These opinions can provide insight into Pila Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Pila Stock Analysis
When running Pila Pharma's price analysis, check to measure Pila Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pila Pharma is operating at the current time. Most of Pila Pharma's value examination focuses on studying past and present price action to predict the probability of Pila Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pila Pharma's price. Additionally, you may evaluate how the addition of Pila Pharma to your portfolios can decrease your overall portfolio volatility.